NCT04447937View on ClinicalTrials.gov

Immunodeficiency in MS

UnknownOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

July 30, 2021

Conditions
Multiple SclerosisHypogammaglobulinemiaImmunodeficiencyInfection, Bacterial
Interventions
OTHER

No Interventions

There are no interventions associated with the study.

Trial Locations (1)

37064

Advanced Neurosciences Institute, Franklin

Sponsors
All Listed Sponsors
collaborator

Novel Pharmaceutics Institute

UNKNOWN

lead

Advanced Neurosciences Institute

OTHER